ImpediMed Limited (ASX:IPD) has disclosed the results of its Annual General Meeting held on 18 November 2026, with all seven resolutions carried, including approval of a change of company name and constitution, and the grant of 109,794,161 performance rights to Chief Executive Officer and Managing Director Mr Erik Anderson.

Key Points

  • All seven resolutions put to the 18 November 2026 AGM were carried.
  • A resolution to change the company name and constitution was carried with 97.77% of votes in favour.
  • The grant of 109,794,161 performance rights to CEO and Managing Director Erik Anderson under the ImpediMed Employee Incentive Plan was carried with 62.53% of votes in favour.
  • The re-election of Ms Fiona Bones as a director was carried with 97.29% of votes in favour, and Ms Janelle Delaney's re-election was carried with 95.83% in favour.
  • The remuneration report received a first strike, with 38.68% of votes cast against the resolution.

Remuneration Report and CEO Termination Benefits Approval

The remuneration report resolution was carried with 61.32% of votes in favour and 38.68% against, attracting a strike under the relevant provisions of the Corporations Act 2001. A separate resolution approving termination benefits for the Chief Executive Officer and Managing Director was also carried, with 61.94% of votes in favour and 38.06% against. The approval of securities issuance under the ImpediMed Employee Incentive Plan was carried with 98.05% of votes in favour and 1.95% against, according to the filing.

Director Re-Elections at the Annual General Meeting

The re-election of Ms Janelle Delaney to the board was carried with 95.83% of total votes cast in favour and 4.17% against. The re-election of Ms Fiona Bones was carried with 97.29% of total votes in favour and 2.71% against. Both resolutions were designated as not subject to a strike. Abstentions were recorded for both resolutions but, as noted in the filing, votes relating to persons who abstain are not counted in determining whether the required majority was achieved.

Company Name Change and Constitution Resolution

A resolution seeking approval for a change of company name and constitution was carried with 97.77% of total votes in favour, with 2.23% against and 805,318 abstentions recorded. The filing does not disclose the proposed new company name. The resolution to grant 109,794,161 performance rights to CEO Erik Anderson under the ImpediMed Employee Incentive Plan was carried with 62.53% of votes in favour and 37.47% against. The AGM results were authorised for release by the Company Secretary of ImpediMed Limited.